Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP976632.RAmsAhgp1lEALrxHxGgjd2YIcl3n6WRLwtR72NY3o0vPc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP976632.RAmsAhgp1lEALrxHxGgjd2YIcl3n6WRLwtR72NY3o0vPc130_assertion type Assertion NP976632.RAmsAhgp1lEALrxHxGgjd2YIcl3n6WRLwtR72NY3o0vPc130_head.
- NP976632.RAmsAhgp1lEALrxHxGgjd2YIcl3n6WRLwtR72NY3o0vPc130_assertion wasGeneratedBy ECO_0000203 NP976632.RAmsAhgp1lEALrxHxGgjd2YIcl3n6WRLwtR72NY3o0vPc130_provenance.
- NP976632.RAmsAhgp1lEALrxHxGgjd2YIcl3n6WRLwtR72NY3o0vPc130_assertion wasDerivedFrom befree-2016 NP976632.RAmsAhgp1lEALrxHxGgjd2YIcl3n6WRLwtR72NY3o0vPc130_provenance.
- NP976632.RAmsAhgp1lEALrxHxGgjd2YIcl3n6WRLwtR72NY3o0vPc130_assertion SIO_000772 22524658 NP976632.RAmsAhgp1lEALrxHxGgjd2YIcl3n6WRLwtR72NY3o0vPc130_provenance.
- NP976632.RAmsAhgp1lEALrxHxGgjd2YIcl3n6WRLwtR72NY3o0vPc130_assertion evidence source_evidence_literature NP976632.RAmsAhgp1lEALrxHxGgjd2YIcl3n6WRLwtR72NY3o0vPc130_provenance.
- NP976632.RAmsAhgp1lEALrxHxGgjd2YIcl3n6WRLwtR72NY3o0vPc130_assertion description "[These findings suggest that CXCR7 is a novel TEC marker and a target for antiangiogenic therapy for RCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP976632.RAmsAhgp1lEALrxHxGgjd2YIcl3n6WRLwtR72NY3o0vPc130_provenance.